Mogamulizumab-kpkc and Novo-Cholamine
Determining the interaction of Mogamulizumab-kpkc and Novo-Cholamine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: cholestyramine
Brand name: Cholestyramine Light, Prevalite, Questran, Questran Light, Locholest, Locholest Light, Questran Light Packets, Prevalite Packets, Questran Packets
Synonyms: Cholestyramine, Cholestyramine Resin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc-Novo-Cholamine Light
- Mogamulizumab-kpkc-Novo-Clavamoxin 125
- Mogamulizumab-kpkc-Novo-Clavamoxin 250
- Mogamulizumab-kpkc-Novo-Furan Suspension
- Mogamulizumab-kpkc-Novo-Hydrocort Cream Topical application
- Mogamulizumab-kpkc-Novo-Hydrocort Topical application
- Novo-Cholamine-Mogamulizumab-kpkc Intravenous
- Novo-Cholamine-Molindone
- Novo-Cholamine-Mometasone (Oral Inhalation)
- Novo-Cholamine-Mometasone and Formoterol
- Novo-Cholamine-Mometasone and formoterol Inhalation
- Novo-Cholamine-Mometasone Cream